Columbia University - Irving Medical Center — New York, New York

Public research footprint of Columbia University - Irving Medical Center, compiled from the ClinicalTrials.gov public registry.

688

Registered studies

369

Active

233

Recruiting now

227

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Muscle Invasive Bladder Urothelial Carcinoma · HER2- Negative Breast Cancer · Advanced Solid Tumor

Recently updated registry entries

NCT07104032 — IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary… (Recruiting)
NCT05902169 — Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU… (Recruiting)
NCT05654922 — Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Columbia University - Irving Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.